TIDMAPH
RNS Number : 9931L
Alliance Pharma PLC
18 May 2022
For immediate release 18 May 2022
ALLIANCE PHARMA PLC
("Alliance" or the "Company")
Result of AGM
Alliance Pharma plc (AIM: APH), the international healthcare
group, announces that, at its Annual General Meeting held earlier
today, all the resolutions, as set out in the Notice of Meeting,
were duly passed on a poll.
The votes were as follows:
RESOLUTION VOTES % VOTES % VOTES % OF VOTES WITHHELD
FOR AGAINST TOTAL ISC VOTED
============================== ============ ======= =========== ====== ============ =========== ===============
1 Report and Accounts 371,393,469 99.99 30,000 0.01 372,087,366 68.97 663,897
2 Final dividend 372,086,356 100.00 0 0.00 372,087,366 68.97 1,010
3 Re-elect P. Butterfield 371,812,794 99.94 238,118 0.06 372,087,366 68.97 36,454
4 Re-elect D. Cook 304,867,206 91.75 27,427,589 8.25 372,087,366 68.97 39,792,571
5 Re-elect A. Franklin 371,701,797 99.91 346,094 0.09 372,087,366 68.97 39,475
6 Re-elect R. Jones 318,832,469 94.70 17,845,835 5.30 372,087,366 68.97 35,409,062
7 Re-elect J. LeCouilliard 283,289,848 84.14 53,391,477 15.86 372,087,366 68.97 35,406,041
8 Elect K. Neirynck 371,168,677 99.76 882,235 0.24 372,087,366 68.97 36,454
9 Re-appoint Auditor 372,018,741 99.99 38,636 0.01 372,087,366 68.97 29,989
Remuneration
10 of Auditor 372,058,198 100.00 2,200 0.00 372,087,366 68.97 26,968
11 Allot shares 314,847,187 84.62 57,236,109 15.38 372,087,366 68.97 4,070
Disapply Pre-emption
12 rights 318,400,733 85.57 53,682,363 14.43 372,087,366 68.97 4,270
The number of the Group's shares in issue as at the date of the
meeting was 539,461,338 ordinary shares of 1p each.
Please note that each share carries one vote and that a 'vote
withheld' is not a vote in law and has not been counted in the
calculation of the proportion of the votes for and against the
resolution. Any proxy appointments which gave discretion to the
Chairman have been included in the 'votes for' total.
Chris Chrysanthou
Head of Legal & Company Secretary
18 May 2022
For further information:
Alliance Pharma plc + 44 (0)1249 466966
Cora McCallum, Head of Investor Relations
& Corporate Communications + 44 (0)1249 705168
ir@allianceph.com
Buchanan + 44 (0)20 7466 5000
Mark Court / Sophie Wills / Hannah Ratcliff
alliancepharma@buchanan.uk.com
Numis Securities Limited + 44 (0)20 7260 1000
Nominated Adviser: Freddie Barnfield / Duncan
Monteith
Corporate Broking: James Black
Investec Bank plc + 44 (0)20 7597 5970
Corporate Finance: Daniel Adams
Corporate Broking: Patrick Robb
About Alliance
Alliance Pharma plc (AIM: APH) is an international healthcare
group. Our purpose is to improve the lives of consumers and
patients through making available a range of clinically valuable
healthcare products.
Our core focus is on the marketing of Consumer Healthcare
brands, complemented by a smaller Prescription Medicines business.
In total, we hold marketing rights to around 80 brands, with
revenues generated from a mix of direct, distributor and e-commerce
sales.
Headquartered in the UK, Alliance employs around 250 people
based in locations across Europe, North America, and the Asia
Pacific region. By outsourcing our manufacturing and logistics
operations, we remain asset-light and focused on maximising the
value of our brands.
For more information on Alliance, please visit our website :
www.alliancepharmaceuticals.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
RAGBKFBQQBKDKPD
(END) Dow Jones Newswires
May 18, 2022 10:42 ET (14:42 GMT)
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Apr 2024 to May 2024
Alliance Pharma (LSE:APH)
Historical Stock Chart
From May 2023 to May 2024